Last updated on April 18, 2014 at 14:31 EDT

Three Hits in the Fight Against Age-Related Macular Degeneration

October 24, 2011

ST. LOUIS, Oct. 24, 2011 /PRNewswire/ — St. Louis-based ZeaVision, LLC announced that three recent groundbreaking studies demonstrate that Zeaxanthin (zee-uh-zan-thin), the predominate protective pigment in the back of the eye, reduces the risk for Age-Related Macular Degeneration (AMD) and benefits the treatment of advanced AMD, a condition that destroys central vision and affects millions of Americans. AMD is the leading cause of blindness in people over age 55, according to the American Optometric Association and the incidence of AMD is expected to triple by 2025. The Centers for Disease Control and Prevention (CDC) estimates 7.3 million people are at risk for vision loss resulting from AMD.

In 2011, two studies in Europe and Asia demonstrate that Zeaxanthin lowers AMD risk. A study from the Erasmus Medical Center Rotterdam in the Netherlands demonstrates that nutrients – specifically dietary Zeaxanthin – reduce the risk of early AMD. The Beijing Tongren Eye Center in China recently published data indicating a direct correlation between higher blood serum levels of Zeaxanthin and a 96% reduction of developing AMD. The third and most recent study in the US, from the Retina Center of St. Louis, shows that an additional 20 mg/per day of Zeaxanthin to patients undergoing therapy for advanced or wet AMD significantly reduces the number of invasive treatment cycles required.

While Zeaxanthin is naturally found in the macula as the primary protective carotenoid, it is difficult to replenish through the average daily diet. For example, one would have to eat approximately 20 ears of corn to get a recommended dosage of 8-10 mg of natural dietary Zeaxanthin per daily serving. ZeaVision’s EyePromise® brand of all-natural nutraceuticals includes patented formulas that contain the highest daily doses of Zeaxanthin available derived from paprika peppers.

Zeaxanthin Study Poster:


More About AMD

AMD destroys central vision through damage to the macula, a small part of the retina in the back of the eye. Key risk factors for AMD include family history, smoking (past or present), age, low macular pigment, light skin and eyes, and obesity. Caucasian women are also at slightly higher risk.

About ZeaVision

ZeaVision is passionate about preserving healthy vision and fighting vision loss. The company develops nutraceutical and technology products for EyeCare Professionals and patients. ZeaVision scientists have conducted more than 20 years of research and development in nutrition and eye health, and hold patents on Zeaxanthin, a natural antioxidant and photo- protectant derived from paprika peppers. The company also offers a state-of-the-art measurement device as part of its Eye-Q(TM) Intelligent AMD Risk Management program. The QuantifEye® instrument measures macular pigment optical density and allows EyeCare Professionals to measure, manage, monitor, and maintain healthy macular pigment levels to address an important AMD risk factor. For more information, please visit http://www.zeavision.com or call 866-833-2800. For more information on the EyePromise® brand of all-natural nutraceuticals for eye health, visit http://www.eyepromise.com.

Logo: http://www.ereleases.com/pic/2011-ZeaVision-logo.gif

ZeaVision, EyePromise, QuantifEye, and Eye-Q are the respective logos and registered trademarks of ZeaVision, LLC. All rights reserved.

For More Information:

Andy Likes
The Vandiver Group, Inc.

This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


Source: PR Newswire